Ligand-gated ion channels (LGICs) are intact membrane proteins capable of carrying orthosteric binding sites for neurotransmitters and ion channels across membranes. LGICs can mediate intercellular communication by translating the binding of neurotransmitters released from the presynaptic terminal into an ion fluxes in the postsynaptic membrane. In addition to the recognized role of LGICs in neurotransmission, some LGICs are critical in non-excitable cells such as endothelial cells, suggestive of a broader functional role of these receptors outside the peripheral and central nervous system. LGICs are associated with several neurodegenerative diseases including Alzheimer's disease and Parkinson's disease, as well as epilepsy, hypertonic plexus disorder, and neuropathic pain, as they are characterized by major LGIC dysfunction. LGICs therefore represent attractive targets for new therapeutic agents.
In order to find attractive targets for new therapeutic agents with improved discrimination between receptor isoforms and a reduced propensity for off-target effects, BOC Sciences can design a novel ligand-gated ion channel library containing 4,000 compounds.
Figure 1. Structure of pentameric LGIC. (Nasiripourdori, A.; et al. 2011)
Figure 2. Structure of tetrameric LGIC. (Nasiripourdori, A.; et al. 2011)
BOC Sciences provides professional, rapid and high-quality services of Ligand-Gated Ion Channel Library design at competitive prices for global customers. Personalized and customized services of Ligand-Gated Ion Channel Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.